# US 2004/0082618 A1 · Liquid dosage forms of acid labile drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082618 A1
- Document ID: US20040082618A1
- Status: Published application
- Kind: A1
- Application number: 10/611,044
- Filed: 2003-07-01
- Published: 2004-04-29
- Earliest claimed: 2002-07-03
- Inventors: Rajneesh Taneja
- Web page: https://patentgrep.com/patent/US20040082618A1

## CPC

- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Liquid formulations of acid-labile drugs are provided. The formulations generally comprise micro-granules comprising an acid-labile drug coated with an enteric coating and a liquid vehicle having a pH less than 6.0. The components of the formulation can separately provided in the form of kits. The formulations and kits may be used to treat patients suffering from disorders for which the acid labile drugs are indicated.

## Claims

### Claim 1

A pharmaceutical formulation comprising:
(a) micro-granules comprising an acid-labile drug coated with an enteric coating; and
(b) a liquid vehicle having a pH less than 6.0.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the micro-granules are between 100 μm and 900 μm.

### Claim 3 (depends on 1)

The composition of claim 1 wherein the acid labile drug is a proton pump inhibitor.

### Claim 4 (depends on 3)

The composition of claim 3 wherein the proton pump inhibitor is Lansoprazole®.

### Claim 5 (depends on 1)

The composition of claim 1 wherein the liquid has a volume of less than 50 ml.

### Claim 6

A method of treating a patient with a gastrointestinal disorder comprising providing to the patient a composition comprising micro-granules of an enterically coated proton pump inhibitor and a liquid vehicle having a pH less than 6.0.

### Claim 7

A kit comprising:
a) a first container comprising micro-granules comprising an acid labile drug coated with an enteric coating; and
b) a second container comprising a liquid vehicle;
wherein the first or the second container further comprises an acidic excipient.

### Claim 8 (depends on 7)

The kit of claim 7 wherein the acid-labile drug is a proton pump inhibitor.

### Claim 9 (depends on 8)

The kit of claim 8 wherein the proton pump inhibitor is Lansoprazole®.

### Claim 10 (depends on 7)

The kit of claim 7 wherein the micro-granules are between 100 μm and 900 μm.

### Claim 11 (depends on 7)

The kit of claim 7 wherein the volume of the liquid vehicle in the second container is less than 50 ml.
